Mizuho analyst Graig Suvannavejh reiterated a Neutral rating and $4.00 price target on Athira Pharma (NASDAQ: ATHA).The analyst comments "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE